{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:05:03Z","timestamp":1790424303709,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.thromres.2018.01.014","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T14:31:51Z","timestamp":1515508311000},"page":"S103-S105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"S1","title":["Thrombotic microangiopathy in cancer"],"prefix":"10.1016","volume":"164","author":[{"given":"Ilene Ceil","family":"Weitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2018.01.014_bb0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2018.01.014_bb0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2018.01.014_bb0015","series-title":"Microangiopthic Anemia in Mucin forming adenocarcinoma BJH","first-page":"183","volume":"18","author":"Brain","year":"1970"},{"key":"10.1016\/j.thromres.2018.01.014_bb0020","doi-asserted-by":"crossref","first-page":"368","DOI":"10.7326\/0003-4819-79-3-368","article-title":"Microangiopathic hemolytic anemia in metastatic carcinoma. Report of eight cases","volume":"79","author":"Lohrmann","year":"1973","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2018.01.014_bb0025","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00005792-197909000-00004","article-title":"Microangiopathic hemolytic anemia and cancer","volume":"58","author":"Antman","year":"1979","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.thromres.2018.01.014_bb0030","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-2000-8469","article-title":"Homocysteine, coagulation, platelet function, and thrombosis","volume":"26","author":"Coppola","year":"2000","journal-title":"Semin. Thromb. Hemost."},{"issue":"167","key":"10.1016\/j.thromres.2018.01.014_bb0035","article-title":"Activation of complement system in adult T-cell leukemia (ATL) occurs mainly through lectin pathway: a serum proteomic approach using mass spectrometry","volume":"271","author":"Ishida","year":"2008","journal-title":"Cancer Lett."},{"issue":"23","key":"10.1016\/j.thromres.2018.01.014_bb0040","doi-asserted-by":"crossref","first-page":"66163","DOI":"10.1158\/1078-0432.CCR-14-1338","article-title":"Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer","volume":"20","author":"Suryawanshi","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.thromres.2018.01.014_bb0045","series-title":"RNA Sequencing Approaches to Identifying Novel Biomarkers for Thromboembolism (VTE) in Lung Cancer","author":"Sussman","year":"2017"},{"issue":"11","key":"10.1016\/j.thromres.2018.01.014_bb0050","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1593\/neo.121262","article-title":"Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization","volume":"14","author":"Nunez-Cruz","year":"2012","journal-title":"Neoplasia"},{"issue":"5","key":"10.1016\/j.thromres.2018.01.014_bb0055","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00428-013-1403-7","article-title":"Platelet-derived growth factor-A and vascular endothelial growth factor-C contribute to the development of pulmonary tumor thrombotic microangiopathy in gastric cancer","volume":"462","author":"Abe","year":"2013","journal-title":"Virchows Arch."},{"key":"10.1016\/j.thromres.2018.01.014_bb0060","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2012-02-412080","article-title":"Thrombin generates previously unidentified C5 products that support terminal complement activation","volume":"120","author":"Krisinger","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2018.01.014_bb0065","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm1419","article-title":"Generation of C5a in the absence of C3: a new complement activation pathway","volume":"12","author":"Huber-Lang","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.thromres.2018.01.014_bb0070","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/01.RES.0000171805.24799.fa","article-title":"Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines","volume":"96","author":"Szotowski","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.thromres.2018.01.014_bb0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-2006-933338","article-title":"Tissue factor in infection and severe inflammation","volume":"32","author":"Levi","year":"2006","journal-title":"Semin. Thromb. Hemost."},{"issue":"3","key":"10.1016\/j.thromres.2018.01.014_bb0080","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.molimm.2013.05.222","volume":"56","author":"Zipfel","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.thromres.2018.01.014_bb0085","first-page":"4794","article-title":"A novel C5a receptor-tissue factor cross talk in neutrophils links innate immunity to coagulation pathways","volume":"177","author":"Riis","year":"2006","journal-title":"J. Immunoass."},{"key":"10.1016\/j.thromres.2018.01.014_bb0090","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1200\/JCO.1989.7.6.781","article-title":"Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry","volume":"7","author":"Lesesne","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.thromres.2018.01.014_bb0095","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/ndt\/gfl507","article-title":"Gemcitabine-induced thrombotic microangiopathy: a systematic review","volume":"21","author":"Izzedine","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.thromres.2018.01.014_bb0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000055365","article-title":"Chemotherapy-related hemolytic-uremic syndrome following treatment of a carcinoma of the nasopharynx","volume":"61","author":"Thurnher","year":"2001","journal-title":"Oncology"},{"key":"10.1016\/j.thromres.2018.01.014_bb0105","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/1097-0142(19890901)64:5<1017::AID-CNCR2820640508>3.0.CO;2-N","article-title":"Carboplatin-associated thrombotic microangiopathic hemolytic anemia","volume":"64","author":"Walker","year":"1989","journal-title":"Cancer"},{"issue":"Suppl. 15","key":"10.1016\/j.thromres.2018.01.014_bb0110","article-title":"Acute changes in endothelial function with cisplatin among germ cell tumor patients","volume":"32","author":"Feldman","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.thromres.2018.01.014_bb0115","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1053\/j.ajkd.2015.02.340","article-title":"Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): an 8-year observational study at a single center Medicine (Baltimore), 2014","volume":"66","author":"Izzedine","year":"2015","journal-title":"Kidney Dis"},{"key":"10.1016\/j.thromres.2018.01.014_bb0120","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.thromres.2018.01.014_bb0125","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/annonc\/mdm454","article-title":"Sutinib induced hypertension, thrombotic microangiopathy, and reversible leukoencephalopathy","volume":"18","author":"Kapiteijn","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.thromres.2018.01.014_bb0130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4143\/crt.2008.40.4.211","article-title":"TTP-HUS associated with sunitinib","volume":"40","author":"Choi","year":"2008","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.thromres.2018.01.014_bb0135","first-page":"29","article-title":"A successful renal transplantation for renal failure after dasatinib-induced thrombotic thrombocytopenic purpura in a patient with imatinib-resistant chronic myelogenous leukemia on nilotnib","volume":"2","author":"Martino","year":"2013","journal-title":"Leuk Res Rep"},{"key":"10.1016\/j.thromres.2018.01.014_bb0140","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/1078155214568580","article-title":"Secondary thrombotic microangiopathy in two patients with Philadelphia-positive hematological malignancies treated with imatinib mesylate","volume":"22","author":"Ojeda-Uribe","year":"2016","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.thromres.2018.01.014_bb0145","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S1470-2045(07)70203-6","article-title":"Gemcitabine-associated thrombotic thrombocytopenic purpura","volume":"8","author":"Zupancic","year":"2007","journal-title":"Lancet Oncol."},{"issue":"S1","key":"10.1016\/j.thromres.2018.01.014_bb0150","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.nephro.2017.01.016","article-title":"Thrombotic microangiopathies and antineoplastic agents","volume":"13","author":"Gange","year":"2017","journal-title":"Nephrol. Ther."},{"key":"10.1016\/j.thromres.2018.01.014_bb0155","first-page":"E30","article-title":"Eculizumab therapy for gemcitabine induced hemolytic uremic syndrome: case series and concise review","volume":"5","author":"Al Ustwani","year":"2014","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.thromres.2018.01.014_bb0160","article-title":"Effective treatment of chemotherapy induced atypical haemolytic uraemic syndrome with eculizumab: a case series of 7 treated patients","author":"Weitz","year":"2017","journal-title":"Brit J Hematol"},{"key":"10.1016\/j.thromres.2018.01.014_bb0165","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1111\/j.1600-6143.2005.01047.x","article-title":"Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys","volume":"5","author":"Sartelet","year":"2005","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.thromres.2018.01.014_bb0170","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00062752-200109000-00004","article-title":"Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"8","author":"Medina","year":"2001","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.thromres.2018.01.014_bb0175","first-page":"493","article-title":"The use of ADAMTS13, platelet count and serum creatinine to differentiate acquired TTP and other thrombotic microangiopathies","volume":"157","author":"Catalan","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.thromres.2018.01.014_bb0180","first-page":"1432","article-title":"The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency","volume":"3","author":"Terrell","year":"2005","journal-title":"JTH"},{"key":"10.1016\/j.thromres.2018.01.014_bb0185","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood-2014-11-611335","article-title":"Drug induced thrombotic microangiopathy: a systemic review of published reports","volume":"125","author":"Al Nouri","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2018.01.014_bb0190","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ajh.23960","article-title":"Drug induced thrombotic microangiopathy: experience of the Oklahoma registry and the Blood Center of Wisconsin","volume":"90","author":"Reese","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2018.01.014_bb0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1076029615598221","article-title":"Hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"22","author":"Elsallabi","year":"2016","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2018.01.014_bb0200","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/bmt.2010.182","article-title":"Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT","volume":"46","author":"Laskin","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.thromres.2018.01.014_bb0205","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2018.01.014_bb0210","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","article-title":"Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"122","author":"Jodele","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2018.01.014_bb0215","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1182\/blood-2015-08-663435","article-title":"The genetic fingerprint of susceptility for transplant-associated thrombotic microangiopathy","volume":"127","author":"Jodele","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2018.01.014_bb0220","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbmt.2013.12.565","article-title":"Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"20","author":"Jodele","year":"2014","journal-title":"Biol. Blood Marrow Transplant."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384818300148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384818300148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,10]],"date-time":"2018-11-10T04:57:55Z","timestamp":1541825875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384818300148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":44,"alternative-id":["S0049384818300148"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2018.01.014","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombotic microangiopathy in cancer","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2018.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}